Identification of Bone Marrow-Derived Soluble Factors Regulating Human Mesenchymal Stem Cells for Bone Regeneration.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28162996)

Published in Stem Cell Reports on February 02, 2017

Authors

Tsung-Lin Tsai1, Wan-Ju Li2

Author Affiliations

1: Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, WI 53705, USA; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA.
2: Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, WI 53705, USA; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA. Electronic address: li@ortho.wisc.edu.

Articles cited by this

Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature (2010) 15.28

Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell (2008) 9.92

The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells (1978) 8.80

In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res (1998) 8.24

Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol (2004) 5.43

Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell (2012) 4.67

Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One (2008) 4.37

No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol (2008) 3.46

The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes (2007) 3.42

An iron delivery pathway mediated by a lipocalin. Mol Cell (2002) 3.38

Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet (1987) 3.35

Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell (2014) 3.13

Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther (2008) 2.25

Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood (2010) 2.22

Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood (1994) 2.14

Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica (2007) 2.07

The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol (2008) 2.00

Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res (2007) 1.99

Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9. Arthritis Rheum (2007) 1.30

Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol (2004) 1.29

Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro. Nat Methods (2014) 1.25

Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev (2010) 1.22

The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev (2004) 1.17

3D niche microarrays for systems-level analyses of cell fate. Nat Commun (2014) 1.10

Transcriptional profile of native CD271+ multipotential stromal cells: evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activity. Arthritis Rheum (2012) 1.09

Effects of medium supplements on proliferation, differentiation potential, and in vitro expansion of mesenchymal stem cells. Stem Cells Transl Med (2012) 1.09

The biosynthesis of human growth hormone and prolactin. J Clin Endocrinol Metab (1970) 1.04

Fibroblast growth factor-2 primes human mesenchymal stem cells for enhanced chondrogenesis. PLoS One (2011) 1.03

Breastfeeding protects against hip fracture in postmenopausal women: the Tromsø study. J Bone Miner Res (2011) 0.92

S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner. J Cell Sci (2011) 0.90

Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress. Cell Stress Chaperones (2014) 0.89

Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulation. Stem Cell Reports (2015) 0.88

Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Mol Cell Endocrinol (2002) 0.87

Alterations in proteins of bone marrow extracellular matrix in undernourished mice. Braz J Med Biol Res (2000) 0.86

Post-traumatic hormonal disturbances: prolactin as a link between head injury and enhanced osteogenesis. J Endocrinol Invest (1998) 0.86

Growth differentiation factor 6 and transforming growth factor-beta differentially mediate mesenchymal stem cell differentiation, composition, and micromechanical properties of nucleus pulposus constructs. Arthritis Res Ther (2014) 0.86

Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments. Cell Stress Chaperones (2013) 0.85

Macrophage migration inhibitory factor regulates AKT signaling in hypoxic culture to modulate senescence of human mesenchymal stem cells. Stem Cells Dev (2014) 0.84

Endothelial cells direct human mesenchymal stem cells for osteo- and chondro-lineage differentiation through endothelin-1 and AKT signaling. Stem Cell Res Ther (2015) 0.82

Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells. Blood (2015) 0.82

A prospective study of bone density and pregnancy after an extended period of lactation with bone loss. Obstet Gynecol (1995) 0.81

Constructing stem cell microenvironments using bioengineering approaches. Physiol Genomics (2013) 0.78

The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis. Cancer Med (2015) 0.78

Gdf6 induces commitment of pluripotent mesenchymal C3H10T1/2 cells to the adipocyte lineage. FEBS J (2013) 0.78

Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. Tissue Eng Part A (2013) 0.78

Ovine bone marrow extracellular matrix and soluble protein extraction: fetuin amino terminus microheterogeneity. Am J Med Sci (1995) 0.76